Distribution Channels

Distribution Channels encompass the pathways, intermediaries, and logistics networks through which pharmaceutical products move from manufacturers to end users including patients, healthcare facilities, pharmacies, and other dispensing locations. These complex supply chains involve multiple participants including wholesalers purchasing bulk products from manufacturers, retail and hospital pharmacies dispensing to patients, specialty distributors handling high-value or special handling products, and group purchasing organisations negotiating on behalf of healthcare systems.

The biopharmaceutical industry navigates increasingly complex distribution networks adapting to diverse product requirements, regulatory constraints, and market dynamics. Traditional distribution flows through large wholesalers to retail pharmacies, while specialty pharmaceuticals often employ limited distribution networks with specialty pharmacies providing patient support services and managing complex reimbursement processes. Biologics and temperature-sensitive products require cold chain distribution maintaining specific temperature ranges throughout transport and storage. Risk evaluation and mitigation strategies may mandate restricted distribution through certified pharmacies and prescribers. Digital transformation enables direct-to-patient delivery for certain products, telehealth prescribing, and enhanced tracking throughout supply chains. As cell and gene therapies emerge requiring patient-specific manufacturing and specialised handling, distribution channel strategies continue adapting ensuring reliable, efficient product delivery maintaining quality while expanding access to transformative therapies globally.